Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.
Wagner KD, Asarnow JR, Vitiello B, Clarke G, Keller M, Emslie GJ, Ryan N, Porta G, Iyengar S, Ritz L, Zelanzny J, Onorato M, Brent D. Wagner KD, et al. Among authors: vitiello b. J Child Adolesc Psychopharmacol. 2012 Feb;22(1):5-10. doi: 10.1089/cap.2011.0045. Epub 2012 Jan 17. J Child Adolesc Psychopharmacol. 2012. PMID: 22251022 Free PMC article. Clinical Trial.
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Volkmar FR, Votolato NA, Walson P. McDougle CJ, et al. Among authors: vitiello b. Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):201-24. Child Adolesc Psychiatr Clin N Am. 2000. PMID: 10674197 Review.
Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.
Scahill L, McCracken J, McDougle CJ, Aman M, Arnold LE, Tierney E, Cronin P, Davies M, Ghuman J, Gonzalez N, Koenig K, Lindsay R, Martin A, McGough J, Posey DJ, Swiezy N, Volkmar F, Ritz L, Vitiello B. Scahill L, et al. Among authors: vitiello b. J Child Adolesc Psychopharmacol. 2001 Winter;11(4):377-88. doi: 10.1089/104454601317261555. J Child Adolesc Psychopharmacol. 2001. PMID: 11838820 Clinical Trial.
Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study.
Walkup J, Labellarte M, Riddle MA, Pine DS, Greenhill L, Fairbanks J, Klein R, Davies M, Sweeney M, Abikoff H, Hack S, Klee B, Bergman RL, Lynn D, McCracken J, March J, Gammon P, Vitiello B, Ritz L, Roper M; Research Units on Pediatric Psychopharmacology Anxiety Study Group. Walkup J, et al. Among authors: vitiello b. J Child Adolesc Psychopharmacol. 2002 Fall;12(3):175-88. doi: 10.1089/104454602760386879. J Child Adolesc Psychopharmacol. 2002. PMID: 12427292 Clinical Trial.
Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders.
Walkup JT, Labellarte MJ, Riddle MA, Pine D, Greenhill L, Klein R, Davies M, Sweeney M, Fu C, Abikoff H, Hack S, Klee B, McCracken J, Bergman L, Piacentini J, March J, Compton S, Robinson J, O'Hara T, Baker S, Vitiello B, Ritz L, Roper M; Research Units on Pediatric Psychopharmacology Anxiety Study Group. Walkup JT, et al. Among authors: vitiello b. J Am Acad Child Adolesc Psychiatry. 2003 Jan;42(1):13-21. doi: 10.1097/00004583-200301000-00006. J Am Acad Child Adolesc Psychiatry. 2003. PMID: 12500072 Clinical Trial.
AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology.
March J, Kratochvil C, Clarke G, Beardslee W, Derivan A, Emslie G, Green EP, Heiligenstein J, Hinshaw S, Hoagwood K, Jensen P, Lavori P, Leonard H, McNulty J, Michaels MA, Mossholder A, Osher T, Petti T, Prentice E, Vitiello B, Wells K. March J, et al. Among authors: vitiello b. J Am Acad Child Adolesc Psychiatry. 2004 Aug;43(8):1046-56. doi: 10.1097/01.chi.0000129606.83206.77. J Am Acad Child Adolesc Psychiatry. 2004. PMID: 15266201
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team. March J, et al. Among authors: vitiello b. JAMA. 2004 Aug 18;292(7):807-20. doi: 10.1001/jama.292.7.807. JAMA. 2004. PMID: 15315995 Clinical Trial.
Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group. Abikoff H, et al. Among authors: vitiello b. J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27. doi: 10.1097/01.chi.0000155320.52322.37. J Am Acad Child Adolesc Psychiatry. 2005. PMID: 15843763 Clinical Trial.
378 results